Activated AKT, which is observed in ~ 70% GBM patients, especially in those with PTEN loss [5], mediates tumor cells proliferation, survival and malignant transformation through multiple downstream targets, including GSK-3, MDM2, and mTOR et al. [6]. Here, PTEN is linked to glioblastoma.